Abstract
BackgroundThe factors contributing to the efficacy of abatacept in patients with rheumatoid arthritis (RA) remain unknown.ObjectivesWe aimed to identify cellular, transcriptomic, and proteomic features that predict responses or resistance to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
